Clerisy Corporation 506(c) Investor Portal

Clerisy Corporation

Revolutionizing the Delivery of Over-the-counter and Prescription Medications

▼  scroll down to learn more  ▼

Clerisy Corporation
506(c) Offering Platform

INTRODUCTION TO OUR COMPANY

Clerisy Corporation, through development and delivery of its revolutionary medical solutions is poised to become a leader in health and wellness channels.

This Information Memorandum (“Memorandum”) has been prepared to showcase the Company’s products and their expected financial impact on the Company and its shareholders for the period 2018-2022. The Company was formed as a corporation in New York in 2005 with offices in New York and Southern California provides revolutionary medical solutions for use across a variety of vertical channels.

Evaluate Pharma, in its annual World Preview report, projects a global growth rate for the pharma industry of 6.3% CAGR through 2022.

Clerisy Corporation
506(c) Offering Platform

Summary of Operations

Clerisy’s initial product line includes a revolutionary medical device which represents the Company’s underlying philosophy of providing products which are consistently recognized as ultra-high quality at competitive prices, and which provide complete satisfaction to the end user.

Additionally, the Company strives to provide its products in a manner which reflects the Company’s belief in the importance of customer satisfaction and increasing sales through product improvements, and the introduction of additional complimentary products and services.

Clerisy provides distinctive, proven medical solutions for consumers focused on healthy living. As a developer of health/wellness and personal care products the Company is keenly focused on major opportunities in the global consumer health market with the goal of being a leader in overall health and wellness solutions, across OTC/ Nutraceuticals and Rx prescription markets.

The Company’s product line includes Clerisy NeuroNasal Strips®, Body Patches® and Ice Strips® comprising a complete solution for consumers, e.g. Clerisy Energy Solution, Clerisy Nausea Solution, Clerisy Sleep Solution, Clerisy Decongestant Solution, Clerisy Stress Solution, Clerisy Appetite Control Solution, etc.

NeuroNasal Strips are an advanced and extraordinarily RAPID therapeutic device that capitalizes on the body’s potent nasal sensory system of 400 receptors, to deliver signals to target regions of the brain which stimulate physical reactions within the body for optimal health benefits.

Body Patches (transdermal) are a complementary, proven Time-Release therapeutic delivery device that support a 24-hour or All Night/Day health & wellness solution by infusing proprietary formulations trans- dermally into the blood stream. (through the skin).

Ice Strips are a complementary and proven FAST onset therapeutic delivery platform to support the Company’s all Day - all Night health & wellness solutions of nutraceutical supplements that cannot be delivered nasally or transdermally.

Clerisy NeuroNasal Strips are extraordinarily FAST acting therapeutic medical devices that activate the highly sensitive nasal sensory system for optimal health benefits.

Clerisy NeuroNasal Strips® are a world first, globally patented, FDA approved Class 1, non-significant risk medication delivery device for use by consumers over the age of 12.

Clerisy Corporation 506(c) Offering Platform

Company Management Team

The Company is currently managed by seasoned business and sector professionals dedicated to the success of the Company and efficient execution of its planned operations

Ross Lyndon James

Ross Lyndon James

Chief Executive Officer

Entrepreneurial business development and investment banking business career that spans 37 years. Experience includes Imax entertainment theaters, apparel manufacturing, advanced semiconductor memory chip development and manufacturing, renewable energy systems, reverse osmosis water treatment and hydroponic plant cultivation. Extensive experience in capital markets including IPOs, mergers and acquisitions. Founder, Chairman & CEO of 6 previously public companies in Australia, US & UK.

Geza Molnar

Geza Molnar

Chief Financial Officer

Senior financial executive who brings over 30 years of financial management, compliance, operational and managerial experience. Experience includes Chief Financial Officer of public and private companies. Broad-ranging experience in the development and management of financial controls, financial reporting, and treasury functions in a growth company environment and experience in directing financial and operational activities of overseas facilities. Qualified as a CPA in 1979 with Price Waterhouse & Co, now part of PricewaterhouseCoopers LLP in Los Angeles. Earned a Bachelor of Arts and Master of Business Administration degrees from the University of Southern California.

Frank Montemurro

Frank Montemurro

Chief Marketing Officer

Professional brand builder who has sold over $1 B on TV and over $500 M to brick & mortar retailers. Seasoned expert in devising marketing strategy, product positioning, brand imagery and advertising. Successfully marketed brands on TV shopping channels including HSN, QVC Worldwide (US, UK, Germany, Italy, Japan and China), TSC (Canada), and HSE24 Germany. Sold to major retailers - Walgreen’s CVS, Walmart, Target, Kroger, Safeway, Publix and Wegmans.

““They’re [Millennial moms] living this natural lifestyle that transcends the [medicines] they buy. It’s inside and outside their bodies, as well as what’s around them. It’s the whole lifestyle of green living.”
- Les Hamilton, president of Hyland’s -

Clerisy Corporation 506(c) Offering Platform

Terms of the offering

$5,000,000

Clerisy Corporation (the “Company” or “Clerisy”) a New York Corporation, is offering one hundred (100) of its 6% Class A Convertible Debentures due in 60 months, consisting of Debentures totaling an aggregate principal face amount not exceeding Five Million Dollars (U.S. $5,000,000.00); which Debentures are being purchased at 100% of face value (See Attached Exhibit A). The Class A Convertible Debentures is also referred to throughout as “Class A unit.”

Have a question about our offering?
Please complete the contact form and we will get back to you.

Clerisy Corporation — Geza Molnar — 31642 Coast Highway, Suite 200 — Laguna Beach, CA 92651 — (949) 456-3972

Clerisy Corporation 506(c) Offering Platform

So Much More than what you See

Placeholder image

The Clerisy Corporation 506(c) Investor Portal provides the opportunity for you to become approved as a “prospect", and learn more about our investment opportunity. You will have:

  • Access to the Private Placement Memorandum, which outlines our comapany and gives greater detail about our offering. Download a PDF to review on your time, read the ebook presentation online or request a hard copy of the documents;
  • Access to our SEC filing. Download a copy for your records or visit the sec.gov website;
  • View real time offering metrics of where we are in the offering process;
  • View the timeline of where you are in the investment process;
  • View company contact information and send emails directly to the administrator;
  • Easily upgrade to "investor" through the click of a button.

We will upgrade your account to “Investor” level access, which provides all of the prospect level access and:

  • The ability to download subscription documents for completion;
  • Document upload of subscription and accredidation documents;
  • Specific process information for investing and instructions on transfer of investment funds;
  • Access to quarterly and annual reports;
  • Access to Financial documents;
  • Access to Supporting Documents;
  • Access to Asset Portfolio;
  • Access to News articles written by the company for the investors;
  • Access to documents that you have uploaded and have been uploaded to your account.
Placeholder image

Ready to learn more about our investment opportunity?

Request Access now!